GlassScriptPhysician profile
Sheena Marie Harmon
NPI 1093154817
$1,767.93
in general payments reported to CMS, 2019-2025
28 companies · $424 in 2025
The $424 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $99.03 · 2021: $132 · 2022: $295 · 2023: $244 · 2024: $340 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $199.43 | 2022-2025 | |
| Astellas Pharma US INC | $199.02 | 2019-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $167.28 | 2020-2025 | Slynd |
| Abbvie INC. | $159.92 | 2019-2022 | |
| Biogen, INC. | $150.64 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $99.98 | 2020-2024 | Aptima |
| Pfizer INC. | $87.31 | 2020-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.97 | 2019-2023 | |
| Agile Therapeutics, INC. | $77.28 | 2021-2024 | Twirla |
| Millicent US INC | $71.00 | 2024-2025 | Intrarosa, Femlyv |
| Organon LLC | $68.46 | 2022-2024 | |
| Daiichi Sankyo INC. | $67.92 | 2019-2020 | |
| Coopersurgical, INC. | $53.23 | 2019-2025 | Paragard T 380a, Sos |
| Evofem Biosciences, INC. | $33.60 | 2022-2025 | Phexxi, Solosec, Phexx |
| Merck Sharp & Dohme LLC | $28.45 | 2022-2025 | Gardasil 9 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $24.75 | 2019 | |
| Meditrina | $19.25 | 2022 | |
| Medtronic, INC. | $18.39 | 2025 | Interstim |
| Myovant Sciences INC. | $17.96 | 2022 | |
| Exact Sciences Corporation | $17.85 | 2025 | The Cologuard Plus Collection Kit |
| Avion Pharmaceuticals | $17.84 | 2019 | |
| Shield Therapeutics INC | $17.11 | 2024 | |
| Solventum Corporation | $15.80 | 2025 | Prevena |
| Sumitomo Pharma America, INC. | $15.76 | 2023 | Myfembree |
| Mylan Pharmaceuticals INC. | $15.21 | 2022 | |
| Aspira Women'S Health INC | $14.27 | 2022 | |
| Therapeuticsmd, INC. | $14.17 | 2021 | |
| Channel Medsystems, INC. | $13.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheena Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.